Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: Will Last Year’s Financing Trends Continue Into Early 2025?

Mar 07 2025

• By Mandy Jackson

Finance Watch Image — • Source: Shutterstock

Related Content

With Q4 Data In, Biopharma VC Fundraising Reached Highest Total Since 2021

Jan 27 2025

Finance Watch: Mega-Rounds Take A Breather After Giving Life To VC Funding In 2024

Mar 03 2025

As Trumps Ups The Ante On Tariffs, Reactions Are Mixed

Mar 04 2025

Mixed Bag For Biopharma Funding In 2025: Thoughts From J.P. Morgan, Biotech Showcase

Jan 23 2025

Sanofi Happy To Spend To Hit Immunology Top Spot

Jan 30 2025

ESMO 24: Nuvation One Step Ahead In Race For ROS1 Lung Cancer Niche

Sep 16 2024

Heplisav-B Approval Has Dynavax Going It Alone On US Launch In Early 2018

Nov 13 2017

Related Companies

Akero Therapeutics, Inc.

Revolution Medicines, Inc.

Stratus Therapeutics, Inc.

Osivax

Sanofi

Nuvation Bio, Inc.

Dynavax Technologies Corporation

Additional Topics

Financing StartUps and SMEs Strategy Business Strategies

More from Finance Watch

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window